Oncotelic Therapeutics Financials

Oncotelic Therapeutics Stock Summary

Oncotelic Therapeutics competes with Processa Pharmaceuticals, Cellectis, Silo Pharma, and Allovir. Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes and CA4P for the treatment of advanced metastatic melanoma. Oncotelic Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.

Oncotelic Therapeutics Key Financial Ratios

Oncotelic Therapeutics' financial ratios allow both analysts and investors to convert raw data from Oncotelic Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Oncotelic Therapeutics over time and compare it to other companies across industries.

Oncotelic Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oncotelic Therapeutics's current stock value. Our valuation model uses many indicators to compare Oncotelic Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncotelic Therapeutics competition to find correlations between indicators driving Oncotelic Therapeutics's intrinsic value. More Info.Oncotelic Therapeutics is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Oncotelic Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Oncotelic Therapeutics' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Oncotelic Therapeutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Oncotelic Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oncotelic Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oncotelic Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Oncotelic OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oncotelic Therapeutics's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

If you are still planning to invest in Oncotelic Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncotelic Therapeutics' history and understand the potential risks before investing.